Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

by Christine Leopold, Christine Y. Lu, Anita K. Wagner
Published 2020-04-01

Policies and programs to facilitate access to targeted cancer therapies in Thailand.

by Rosarin Sruamsiri, Dennis Ross-Degnan, Christine Y Lu, Nathorn Chaiyakunapruk, Anita K Wagner
Published 2015-01-01

1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities

by Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan
Published 2020-09-01

Need for and access to health care and medicines: are there gender inequities?

by Anita K Wagner, Amy J Graves, Zhengyu Fan, Saul Walker, Fang Zhang, Dennis Ross-Degnan
Published 2013-01-01

The Brazilian private pharmaceutical market after the first ten years of the generics law

by Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan
Published 2019-08-01

Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China

by Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD
Published 2013-10-01

Essential medicines for universal health coverage

by Veronika J Wirtz, Hans V Hogerzeil, Andrew L Gray, Maryam Bigdeli, Cornelis de Joncheere, Margaret A Ewen, Martha Gyansa-Lutterodt, Sun Jing, Vera L Luiza, Regina M Mbindyo, Helene Möller, Corrina Moucheraud, Bernard Pécoul, Lembit Rägo, Arash Rashidian, Dennis Ross-Degnan, Peter N Stephens, Yot Teerawattananon, Ellen ‘t Hoen, Anita K Wagner, Prashant Yadav, Michael R Reich
Published 2019-12-01